Oral Session 3-10D MPN: Clinical (2)

[OS3-10D-3] Cytoreductive therapy prevents worsening of renal function in patients with primary myelofibrosis

Yasutaka Fukuda¹, Marito Araki², Kouji Yamamoto³, Soji Morishita², Tadaaki Inano¹, Kyohei Misawa¹, Tomonori Ochiai¹, Yoko Edahiro¹, Misa Imai^1,4, Akihiko Gotoh¹, Akimichi Ohsaka², Norio Komatsu¹ (1.Hematology, Juntendo Univ., Tokyo, Japan, 2.Transfusion Medicine and Stem Cell Regulation, Juntendo Univ., Tokyo, Japan, 3.Medical Statistics, Osaka City Univ., Osaka, Japan, 4.Lead. Cent. Dev. Res. Cencer Med., Juntendo Univ., Tokyo, Japan)